Skip to content
Capsul News Capsul News
5 min read Therapeutic Thursday

Therapeutic Thursday: Cost Cutting For Pace Or For Profitability

AstraZeneca is trimming a boot that fits, cutting $1.5bn in costs while revenues grow 7%. Ultragenyx is cutting into one that never did, losing a fifth of its workforce and a gene therapy in a push for profitability in 2027.

A batter in white kit and a red helmet leans back with his bat raised as a ball passes close to his body, while a fielder in white crouches behind him on a green cricket pitch, with stumps to
Eyes on the ball, not the stands. Photo by michael weir on Unsplash
Share Share Share Email

Read next

Watchdog Wednesday: Wellness Peptides And The Health Of The US FDA

The Long View: Big Pharma’s Obesity Shopping Moves Beyond The Incretin

More from this edition